| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.37▼ | 1.39▼ | 1.39▼ | 1.47▼ | 1.67▼ |
| MA10 | 1.41▼ | 1.43▼ | 1.42▼ | 1.56▼ | 1.74▼ |
| MA20 | 1.50▼ | 1.50▼ | 1.53▼ | 1.69▼ | 1.61▼ |
| MA50 | 1.61▼ | 1.68▼ | 1.70▼ | 1.79▼ | N/A |
| MA100 | 1.75▼ | 1.76▼ | 1.76▼ | 1.64▼ | N/A |
| MA200 | 1.78▼ | 1.89▼ | 1.84▼ | N/A | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.015▼ | -0.010▼ | -0.014▼ | -0.040▼ | 0.041▲ |
| RSI | 34.199▼ | 32.566▼ | 29.442▼ | 32.176▼ | 44.756▼ |
| STOCH | 7.700▼ | 7.143▼ | 4.762▼ | 11.977▼ | 13.025▼ |
| WILL %R | -100.000▼ | -100.000▼ | -100.000▼ | -93.548▼ | -98.131▼ |
| CCI | -108.130▼ | -125.478▼ | -115.732▼ | -195.340▼ | -168.101▼ |
|
Friday, August 15, 2025 04:56 AM
Patient enrollment for our ongoing Phase-3 clinical trial of SGT-610 for Gorlin Syndrome has been completed; top-line results are expect ...
|
|
Friday, August 15, 2025 04:10 AM
Patient enrollment for our ongoing Phase-3 clinical trial of SGT-610 for Gorlin Syndrome has been completed; top-line results are expected in the fourth quarter of 2026Phase-1b proof-of-concept ...
|
|
Wednesday, August 13, 2025 11:01 AM
Net Revenue Outlook for 2025 Increased from $4.2 Million+ to $6.3 Million+, Representing Growth of 102%+, Based on Recent Transformative Merger with Gummy USA LAS VEGAS, NV / ACCESS Newswire / August ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 15/08/25 | 1.40 | 1.40 | 1.29 | 1.33 | 42,800 |
| 14/08/25 | 1.39 | 1.51 | 1.39 | 1.42 | 113,741 |
| 13/08/25 | 1.50 | 1.8899 | 1.3751 | 1.42 | 927,279 |
| 12/08/25 | 1.59 | 1.6199 | 1.50 | 1.54 | 50,495 |
| 11/08/25 | 1.64 | 1.6488 | 1.604 | 1.62 | 26,775 |
| 08/08/25 | 1.73 | 1.81 | 1.63 | 1.66 | 103,100 |
| 07/08/25 | 1.65 | 1.67 | 1.58 | 1.58 | 28,579 |
| 06/08/25 | 1.645 | 1.70 | 1.6201 | 1.6847 | 58,745 |
| 05/08/25 | 1.67 | 1.717 | 1.65 | 1.66 | 25,400 |
| 04/08/25 | 1.6709 | 1.71 | 1.58 | 1.67 | 90,917 |
|
|
||||
|
|
||||
|
|